Central alpha-2 Adrenergic Agonist [EPC]

Central alpha-2 Adrenergic Agonist [EPC] was reported 53980 times

These side effects are most commonly reported by patients taking drugs of the Central alpha-2 Adrenergic Agonist [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 4256
1 PAIN 3197
2 FATIGUE 3163
3 OFF LABEL USE 3152
4 NAUSEA 3149
5 HEADACHE 3070
6 HYPERTENSION 2856
7 DYSPNOEA 2451
8 DIARRHOEA 2403
9 VOMITING 2206
10 CHRONIC KIDNEY DISEASE 2120
11 DIZZINESS 2043
12 RENAL FAILURE 1935
13 BLOOD PRESSURE INCREASED 1922
14 ACUTE KIDNEY INJURY 1865
15 ANXIETY 1714
16 HYPOTENSION 1654
17 DEATH 1589
18 ASTHENIA 1524
19 FALL 1451
20 BACK PAIN 1445
21 RASH 1443
22 CONSTIPATION 1421
23 INSOMNIA 1415
24 PYREXIA 1400
25 MALAISE 1362
26 WEIGHT DECREASED 1349
27 COMPLETED SUICIDE 1337
28 PNEUMONIA 1313
29 HYPERHIDROSIS 1303
30 SOMNOLENCE 1255
31 ARTHRALGIA 1222
32 OVERDOSE 1216
33 PAIN IN EXTREMITY 1198
34 TOXICITY TO VARIOUS AGENTS 1198
35 END STAGE RENAL DISEASE 1124
36 WEIGHT INCREASED 1120
37 DEPRESSION 1093
38 PRURITUS 1082
39 PRODUCT USE ISSUE 1076
40 DECREASED APPETITE 1045
41 HYPERSENSITIVITY 1039
42 CONDITION AGGRAVATED 1033
43 COUGH 1030
44 CHEST PAIN 1019
45 FEELING ABNORMAL 999
46 ABDOMINAL PAIN 961
47 DRUG INTERACTION 951
48 DRUG HYPERSENSITIVITY 894
49 TREMOR 892
50 ERYTHEMA 880
51 CEREBROVASCULAR ACCIDENT 865
52 INFUSION SITE PAIN 845
53 URINARY TRACT INFECTION 832
54 OEDEMA PERIPHERAL 821
55 CARDIAC FAILURE CONGESTIVE 788
56 ASTHMA 787
57 GAIT DISTURBANCE 780
58 ANAEMIA 778
59 ABDOMINAL PAIN UPPER 774
60 BRADYCARDIA 771
61 DRUG WITHDRAWAL SYNDROME 748
62 FLUID RETENTION 748
63 HYPOAESTHESIA 745
64 CONFUSIONAL STATE 738
65 MYOCARDIAL INFARCTION 728
66 JOINT SWELLING 726
67 MUSCLE SPASMS 721
68 HEPATIC ENZYME INCREASED 713
69 SEIZURE 698
70 PRODUCT DOSE OMISSION ISSUE 690
71 DEHYDRATION 685
72 RHEUMATOID ARTHRITIS 683
73 INTENTIONAL PRODUCT MISUSE 680
74 UPPER RESPIRATORY TRACT INFECTION 680
75 LOSS OF CONSCIOUSNESS 666
76 PRODUCT ADHESION ISSUE 663
77 PRODUCT USE IN UNAPPROVED INDICATION 661
78 PERIPHERAL SWELLING 653
79 RENAL INJURY 645
80 AGITATION 624
81 CARDIAC ARREST 619
82 INFECTION 618
83 PRODUCT QUALITY ISSUE 612
84 RASH ERYTHEMATOUS 596
85 ABDOMINAL DISCOMFORT 593
86 AGGRESSION 592
87 BLOOD GLUCOSE INCREASED 592
88 VISION BLURRED 579
89 IMMUNODEFICIENCY 574
90 APPLICATION SITE PRURITUS 569
91 THROMBOCYTOPENIA 566
92 NEPHROGENIC ANAEMIA 564
93 MUSCULAR WEAKNESS 562
94 HEART RATE INCREASED 558
95 INFUSION RELATED REACTION 554
96 EXPOSURE DURING PREGNANCY 551
97 FOOD ALLERGY 548
98 MYALGIA 543
99 PARAESTHESIA 540
100 APPLICATION SITE ERYTHEMA 538
101 EMOTIONAL DISTRESS 535
102 DRUG INTOLERANCE 534
103 TACHYCARDIA 531
104 INFUSION SITE ERYTHEMA 530
105 ALOPECIA 529
106 DRY MOUTH 528
107 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 528
108 SEPSIS 524
109 GASTROOESOPHAGEAL REFLUX DISEASE 514
110 PALPITATIONS 507
111 SYNCOPE 500
112 DRUG DOSE OMISSION 499
113 PRESCRIBED OVERDOSE 498
114 NASOPHARYNGITIS 489
115 LETHARGY 480
116 SUICIDAL IDEATION 477
117 DRUG DEPENDENCE 471
118 CONTUSION 469
119 URTICARIA 469
120 MEMORY IMPAIRMENT 467
121 CHILLS 465
122 BLOOD PRESSURE DECREASED 462
123 RESPIRATORY FAILURE 461
124 TREATMENT FAILURE 460
125 ATRIAL FIBRILLATION 451
126 INJECTION SITE PAIN 446
127 PSORIASIS 442
128 RENAL IMPAIRMENT 442
129 HAEMOGLOBIN DECREASED 438
130 WITHDRAWAL SYNDROME 438
131 BLOOD CREATININE INCREASED 437
132 INCORRECT DOSE ADMINISTERED 430
133 TEMPERATURE REGULATION DISORDER 430
134 MENTAL STATUS CHANGES 428
135 BURSITIS 427
136 GASTROINTESTINAL HAEMORRHAGE 425
137 DYSPEPSIA 421
138 HALLUCINATION 419
139 ABDOMINAL DISTENSION 416
140 INJURY 416
141 DYSPHAGIA 415
142 COELIAC DISEASE 411
143 MIGRAINE 410
144 DIABETES MELLITUS 402
145 CARDIO-RESPIRATORY ARREST 390
146 DRUG ABUSE 389
147 SINUSITIS 389
148 SEDATION 386
149 GENERAL PHYSICAL HEALTH DETERIORATION 376
150 NEUROPATHY PERIPHERAL 376
151 CONTRAINDICATED PRODUCT ADMINISTERED 375
152 INFUSION SITE SWELLING 374
153 IRRITABILITY 369
154 HOSPITALISATION 367
155 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 367
156 RENAL FAILURE ACUTE 366
157 CHEST DISCOMFORT 364
158 FLUSHING 364
159 INFLUENZA 364
160 INTENTIONAL OVERDOSE 364
161 SWELLING 363
162 SLEEP DISORDER 346
163 BALANCE DISORDER 333
164 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 332
165 OEDEMA 331
166 OXYGEN SATURATION DECREASED 329
167 CONVULSION 325
168 THERAPY NON-RESPONDER 325
169 ABNORMAL BEHAVIOUR 319
170 CELLULITIS 318
171 APPLICATION SITE RASH 317
172 CARDIAC DISORDER 316
173 COVID-19 316
174 BRONCHITIS 313
175 ILLNESS 313
176 STRESS 313
177 VISUAL IMPAIRMENT 313
178 TREATMENT NONCOMPLIANCE 312
179 EPISTAXIS 309
180 UNEVALUABLE EVENT 308
181 DEVICE ISSUE 306
182 BURNING SENSATION 302
183 PRODUCT SUBSTITUTION ISSUE 299
184 MOBILITY DECREASED 298
185 PULMONARY OEDEMA 298
186 DYSKINESIA 297
187 HYPERPARATHYROIDISM SECONDARY 296
188 PLATELET COUNT DECREASED 295
189 DISTURBANCE IN ATTENTION 294
190 RENAL DISORDER 294
191 OBESITY 293
192 HYPERKALAEMIA 292
193 OROPHARYNGEAL PAIN 292
194 CORONARY ARTERY DISEASE 288
195 TYPE 2 DIABETES MELLITUS 288
196 HEART RATE DECREASED 284
197 HYPOKALAEMIA 283
198 NECK PAIN 283
199 SPEECH DISORDER 283
200 ANHEDONIA 282
201 MUSCULOSKELETAL STIFFNESS 278
202 SUICIDE ATTEMPT 278
203 HYPOGLYCAEMIA 276
204 AMNESIA 275
205 RESPIRATORY DEPRESSION 274
206 MEDICATION ERROR 273
207 BLOOD PRESSURE FLUCTUATION 272
208 HYPONATRAEMIA 268
209 DEPRESSED LEVEL OF CONSCIOUSNESS 266
210 NO ADVERSE EVENT 265
211 PLEURAL EFFUSION 263
212 FOETAL DEATH 259
213 STOMATITIS 259
214 RESPIRATORY ARREST 257
215 DELIRIUM 256
216 NERVOUSNESS 256
217 HYPERTENSIVE CRISIS 255
218 BLOOD PRESSURE INADEQUATELY CONTROLLED 254
219 HAEMORRHAGE 254
220 INTENTIONAL PRODUCT USE ISSUE 252
221 UNRESPONSIVE TO STIMULI 252
222 ELECTROCARDIOGRAM QT PROLONGED 250
223 THERAPEUTIC RESPONSE DECREASED 250
224 DRUG EFFECT DECREASED 249
225 PANCREATITIS 249
226 RHABDOMYOLYSIS 249
227 CARDIAC FAILURE 248
228 RESTLESSNESS 245
229 ADVERSE DRUG REACTION 244
230 BLISTER 244
231 CATARACT 244
232 GASTROINTESTINAL DISORDER 243
233 PSYCHOMOTOR HYPERACTIVITY 243
234 THROMBOSIS 243
235 INFUSION SITE HAEMORRHAGE 242
236 HYPOXIA 241
237 WHEEZING 240
238 PULMONARY EMBOLISM 239
239 MUSCULOSKELETAL PAIN 237
240 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 236
241 BLOOD CHOLESTEROL INCREASED 235
242 FEELING HOT 235
243 HOT FLUSH 234
244 DEVICE MALFUNCTION 233
245 TUBULOINTERSTITIAL NEPHRITIS 233
246 SWELLING FACE 232
247 OSTEOARTHRITIS 230
248 BONE PAIN 228
249 TRANSIENT ISCHAEMIC ATTACK 227
250 COMA 226
251 WHITE BLOOD CELL COUNT DECREASED 226
252 ACUTE MYOCARDIAL INFARCTION 224
253 DRY SKIN 222
254 ANGER 221
255 POOR QUALITY SLEEP 221
256 DYSGEUSIA 220
257 SINUS BRADYCARDIA 217
258 ARTHRITIS 216
259 CRYING 216
260 SKIN DISCOLOURATION 214
261 ADVERSE EVENT 213
262 NASAL CONGESTION 212
263 NEUTROPENIA 212
264 UNDERDOSE 211
265 DEVICE DISLOCATION 210
266 HYPERGLYCAEMIA 208
267 INFLUENZA LIKE ILLNESS 208
268 ACCIDENTAL OVERDOSE 207
269 APPLICATION SITE IRRITATION 205
270 DYSARTHRIA 204
271 DISORIENTATION 202
272 DYSPHONIA 201
273 ROAD TRAFFIC ACCIDENT 201
274 DEEP VEIN THROMBOSIS 200
275 DEPRESSED MOOD 198
276 DEVICE FAILURE 198
277 RHINORRHOEA 198
278 SLEEP APNOEA SYNDROME 198
279 URINARY INCONTINENCE 198
280 WRONG TECHNIQUE IN DRUG USAGE PROCESS 197
281 ECONOMIC PROBLEM 196
282 MENTAL DISORDER 195
283 HERPES ZOSTER 194
284 BLOOD GLUCOSE DECREASED 191
285 DISEASE PROGRESSION 189
286 ARRHYTHMIA 188
287 DYSPNOEA EXERTIONAL 188
288 STAPHYLOCOCCAL INFECTION 188
289 HAEMATURIA 186
290 HYPERSOMNIA 186
291 TINNITUS 185
292 APPLICATION SITE PAIN 184
293 DEVICE INFUSION ISSUE 184
294 BLOOD PRESSURE ABNORMAL 183
295 FEAR 182
296 HYPERLIPIDAEMIA 180
297 PANIC ATTACK 180
298 RESPIRATORY DISTRESS 180
299 DYSURIA 179
300 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 179
301 DYSTONIA 178
302 RETCHING 178
303 SUSPECTED SUICIDE 178
304 HYPOPHAGIA 177
305 BLOOD PRESSURE SYSTOLIC INCREASED 176
306 FIBROMYALGIA 175
307 FLATULENCE 175
308 VERTIGO 175
309 CYSTITIS 174
310 REBOUND ACID HYPERSECRETION 174
311 MOOD SWINGS 172
312 SKIN EXFOLIATION 172
313 BLOOD POTASSIUM DECREASED 171
314 DERMATITIS CONTACT 171
315 RECTAL HAEMORRHAGE 171
316 EMOTIONAL DISORDER 170
317 TARDIVE DYSKINESIA 169
318 EXTRAPYRAMIDAL DISORDER 167
319 ANAPHYLACTIC REACTION 166
320 HAEMATOCHEZIA 166
321 POLLAKIURIA 166
322 DISCOMFORT 165
323 OSTEOPOROSIS 164
324 SKIN DISORDER 164
325 INFUSION SITE INFECTION 162
326 LUNG DISORDER 162
327 DEVICE OCCLUSION 161
328 PRODUCT DOSE OMISSION 161
329 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 161
330 MATERNAL EXPOSURE DURING PREGNANCY 160
331 GYNAECOMASTIA 159
332 PAIN IN JAW 159
333 ALANINE AMINOTRANSFERASE INCREASED 158
334 RENAL TUBULAR NECROSIS 158
335 RENAL FAILURE CHRONIC 157
336 SEROTONIN SYNDROME 157
337 VIRAL INFECTION 157
338 DEVICE LEAKAGE 156
339 IMPAIRED HEALING 156
340 INFLAMMATION 156
341 INFUSION SITE DISCHARGE 156
342 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 156
343 METABOLIC ACIDOSIS 155
344 NEPHROPATHY 155
345 ASPARTATE AMINOTRANSFERASE INCREASED 154
346 PRODUCT PRESCRIBING ERROR 154
347 GASTRITIS 153
348 WHITE BLOOD CELL COUNT INCREASED 152
349 SEPTIC SHOCK 151
350 HYPOTHYROIDISM 150
351 TOXIC EPIDERMAL NECROLYSIS 149
352 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 147
353 INJECTION SITE REACTION 147
354 LEUKOPENIA 147
355 JOINT STIFFNESS 146
356 THERAPY INTERRUPTED 146
357 URINARY RETENTION 146
358 DRUG ADMINISTRATION ERROR 145
359 EYE PAIN 145
360 FEBRILE NEUTROPENIA 144
361 FOETAL EXPOSURE DURING PREGNANCY 144
362 POISONING 144
363 PRESYNCOPE 144
364 INJECTION SITE ERYTHEMA 143
365 PULMONARY HYPERTENSION 143
366 NIGHTMARE 142
367 NEPHROGENIC SYSTEMIC FIBROSIS 141
368 ILL-DEFINED DISORDER 139
369 RASH PRURITIC 139
370 ACUTE RESPIRATORY FAILURE 137
371 HEAD INJURY 137
372 MOVEMENT DISORDER 137
373 PANCYTOPENIA 137
374 CROHN^S DISEASE 136
375 LYMPHADENOPATHY 136
376 NEUROLEPTIC MALIGNANT SYNDROME 136
377 SWOLLEN TONGUE 136
378 APHASIA 135
379 IMPAIRED QUALITY OF LIFE 135
380 NEPHROLITHIASIS 135
381 CHOLELITHIASIS 134
382 SURGERY 134
383 BONE DENSITY DECREASED 133
384 CARDIOMEGALY 132
385 IMPAIRED GASTRIC EMPTYING 132
386 THERAPEUTIC RESPONSE UNEXPECTED 132
387 ANGINA PECTORIS 131
388 ARTHROPATHY 131
389 BLOOD SODIUM DECREASED 131
390 JOINT RANGE OF MOTION DECREASED 131
391 MOOD ALTERED 131
392 THERAPY CESSATION 131
393 INFUSION SITE REACTION 130
394 BLOOD POTASSIUM INCREASED 128
395 EAR INFECTION 128
396 PSYCHOTIC DISORDER 128
397 THROAT IRRITATION 128
398 COGNITIVE DISORDER 127
399 BLOOD UREA INCREASED 126
400 ENCEPHALOPATHY 126
401 GOUT 126
402 PERICARDIAL EFFUSION 126
403 RESPIRATORY DISORDER 126
404 HAEMORRHOIDS 125
405 ANGIOEDEMA 124
406 DYSSTASIA 124
407 GAIT INABILITY 124
408 SKIN BURNING SENSATION 124
409 FLUID OVERLOAD 123
410 INFUSION SITE PRURITUS 123
411 FEELING COLD 122
412 PRODUCTIVE COUGH 122
413 BLOOD TRIGLYCERIDES INCREASED 121
414 DRY EYE 121
415 IMPAIRED WORK ABILITY 121
416 NEURALGIA 121
417 NIGHT SWEATS 121
418 APPLICATION SITE VESICLES 120
419 HAEMATOCRIT DECREASED 120
420 INTERNATIONAL NORMALISED RATIO INCREASED 120
421 MUSCLE TWITCHING 119
422 HAEMATOMA 118
423 HYPERAESTHESIA 118
424 INFUSION SITE INDURATION 117
425 INTESTINAL OBSTRUCTION 117
426 LIMB INJURY 117
427 LIP SWELLING 117
428 SKIN LESION 116
429 STEVENS-JOHNSON SYNDROME 116
430 HALLUCINATION, VISUAL 115
431 MULTI-ORGAN FAILURE 115
432 PALLOR 115
433 WOUND 115
434 BLINDNESS 114
435 LACTIC ACIDOSIS 114
436 LEFT VENTRICULAR HYPERTROPHY 114
437 MALIGNANT NEOPLASM PROGRESSION 114
438 MUCOSAL INFLAMMATION 114
439 PNEUMONIA ASPIRATION 114
440 ABASIA 112
441 INJECTION SITE BRUISING 112
442 IRRITABLE BOWEL SYNDROME 112
443 LEUKOCYTOSIS 112
444 HEART RATE IRREGULAR 111
445 CARDIOMYOPATHY 110
446 CEREBRAL HAEMORRHAGE 110
447 GASTROENTERITIS VIRAL 110
448 PROTEINURIA 110
449 PULMONARY CONGESTION 110
450 SKIN ULCER 110
451 EYE DISORDER 109
452 HALLUCINATION, AUDITORY 109
453 HYPOACUSIS 109
454 PANCREATITIS ACUTE 109
455 PARADOXICAL DRUG REACTION 109
456 PRODUCT PACKAGING QUANTITY ISSUE 109
457 DIABETES MELLITUS INADEQUATE CONTROL 108
458 DIALYSIS 108
459 HAEMOPTYSIS 108
460 LOWER RESPIRATORY TRACT INFECTION 108
461 MANIA 108
462 MIDDLE INSOMNIA 108
463 MIOSIS 108
464 BLOOD CREATINE PHOSPHOKINASE INCREASED 107
465 EYE SWELLING 107
466 HEPATIC STEATOSIS 107
467 INFUSION SITE IRRITATION 107
468 NO THERAPEUTIC RESPONSE 107
469 ORAL PAIN 107
470 AKATHISIA 105
471 BODY TEMPERATURE INCREASED 105
472 HAEMATEMESIS 105
473 KIDNEY INFECTION 105
474 TIC 105
475 DEVICE USE ERROR 104
476 EYE IRRITATION 104
477 GENERALISED TONIC-CLONIC SEIZURE 104
478 MUSCLE SPASTICITY 104
479 ORTHOSTATIC HYPOTENSION 104
480 COAGULOPATHY 103
481 LOCALISED INFECTION 103
482 PARANOIA 103
483 TENDERNESS 103
484 ANURIA 102
485 DIVERTICULITIS 102
486 OSTEOMYELITIS 102
487 LIMB DISCOMFORT 101
488 RED BLOOD CELL COUNT DECREASED 101
489 VISUAL ACUITY REDUCED 101
490 ASCITES 100
491 DEVICE MAINTENANCE ISSUE 100
492 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 100
493 HYPERCHOLESTEROLAEMIA 100
494 INTERVERTEBRAL DISC PROTRUSION 100
495 SKIN IRRITATION 100
496 ACCIDENTAL EXPOSURE TO PRODUCT 99
497 INCREASED APPETITE 99
498 DEVICE DIFFICULT TO USE 98
499 INJECTION SITE HAEMORRHAGE 98
500 EAR PAIN 97
501 EATING DISORDER 97
502 INJECTION SITE MASS 97
503 MENTAL IMPAIRMENT 97
504 SCAR 97
505 APPLICATION SITE BURN 96
506 COLITIS 96
507 DRUG EFFECT INCOMPLETE 96
508 DRUG TOXICITY 96
509 HIP FRACTURE 96
510 HYPOTONIA 96
511 KIDNEY TRANSPLANT REJECTION 96
512 RESTLESS LEGS SYNDROME 96
513 APLASTIC ANAEMIA 95
514 ARTERIOSCLEROSIS 95
515 COLD SWEAT 95
516 NERVOUS SYSTEM DISORDER 95
517 PHARMACEUTICAL PRODUCT COMPLAINT 95
518 SUPRAVENTRICULAR TACHYCARDIA 95
519 THERAPY PARTIAL RESPONDER 95
520 ACTIVITIES OF DAILY LIVING IMPAIRED 94
521 DIPLOPIA 94
522 FEEDING DISORDER 94
523 HYPOTHERMIA 94
524 JOINT DISLOCATION 94
525 MYOCLONUS 93
526 THERAPEUTIC PRODUCT EFFECT DECREASED 93
527 DIABETIC KETOACIDOSIS 92
528 GASTRIC DISORDER 92
529 HIATUS HERNIA 92
530 INTENTIONAL DRUG MISUSE 92
531 DRUG LEVEL INCREASED 91
532 PRODUCT AVAILABILITY ISSUE 91
533 RASH MACULAR 91
534 GLUCOSE TOLERANCE IMPAIRED 90
535 INTENTIONAL SELF-INJURY 90
536 LIVER INJURY 90
537 ORAL HERPES 90
538 PERITONITIS 90
539 SCIATICA 90
540 THROAT TIGHTNESS 90
541 BRAIN INJURY 89
542 BREAST CANCER 89
543 DRUG PRESCRIBING ERROR 89
544 INJECTION SITE SWELLING 89
545 SEASONAL ALLERGY 89
546 CARDIOGENIC SHOCK 88
547 DEVICE POWER SOURCE ISSUE 88
548 GALLBLADDER DISORDER 88
549 POST PROCEDURAL COMPLICATION 88
550 BLOOD ALKALINE PHOSPHATASE INCREASED 87
551 FUNGAL INFECTION 87
552 INFUSION SITE WARMTH 87
553 LABORATORY TEST ABNORMAL 87
554 TOOTH LOSS 87
555 ABNORMAL DREAMS 86
556 CANDIDA INFECTION 86
557 PRODUCT PRESCRIBING ISSUE 86
558 INCORRECT DRUG ADMINISTRATION DURATION 85
559 MUSCLE TIGHTNESS 85
560 RENAL CYST 85
561 BLOOD URINE PRESENT 84
562 BONE DISORDER 84
563 DEVICE RELATED INFECTION 84
564 HOMICIDAL IDEATION 84
565 INTENTIONAL DOSE OMISSION 84
566 JOINT INJURY 84
567 LIVER DISORDER 84
568 NEOPLASM MALIGNANT 84
569 PERITONITIS BACTERIAL 84
570 PURULENT DISCHARGE 84
571 ACUTE RESPIRATORY DISTRESS SYNDROME 83
572 APNOEA 83
573 BACK DISORDER 83
574 BIPOLAR DISORDER 83
575 CHROMATURIA 83
576 FOOT FRACTURE 83
577 FULL BLOOD COUNT DECREASED 83
578 LOWER LIMB FRACTURE 83
579 OCULAR HYPERAEMIA 83
580 SHOCK 83
581 ASPIRATION 82
582 ATELECTASIS 82
583 CARDIOVASCULAR DISORDER 82
584 DRUG SCREEN POSITIVE 82
585 INJECTION SITE PRURITUS 82
586 THIRST 82
587 COORDINATION ABNORMAL 81
588 GLYCOSYLATED HAEMOGLOBIN INCREASED 81
589 MOUTH ULCERATION 81
590 OSTEOPENIA 81
591 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 81
592 BACTERIAL INFECTION 80
593 MULTIPLE ORGAN DYSFUNCTION SYNDROME 80
594 SINUS DISORDER 80
595 UPPER LIMB FRACTURE 80
596 C-REACTIVE PROTEIN INCREASED 79
597 CATATONIA 79
598 FEELING JITTERY 79
599 HEMIPARESIS 79
600 RASH GENERALISED 79
601 DEMENTIA 78
602 ILEUS 78
603 INTERVERTEBRAL DISC DEGENERATION 78
604 MITRAL VALVE INCOMPETENCE 78
605 ACNE 77
606 DECREASED ACTIVITY 77
607 DEVICE BREAKAGE 77
608 HYPOKINESIA 77
609 MYDRIASIS 77
610 PHARYNGEAL OEDEMA 77
611 SINUS TACHYCARDIA 77
612 ANKLE FRACTURE 76
613 ELECTROLYTE IMBALANCE 76
614 SPINAL OSTEOARTHRITIS 76
615 DISEASE RECURRENCE 75
616 HAEMORRHAGE INTRACRANIAL 75
617 MYOCARDIAL ISCHAEMIA 75
618 VENTRICULAR TACHYCARDIA 75
619 ALTERED STATE OF CONSCIOUSNESS 74
620 CORONARY ARTERY OCCLUSION 74
621 DECREASED IMMUNE RESPONSIVENESS 74
622 DRUG TOLERANCE 74
623 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 74
624 INFUSION SITE NODULE 74
625 MALNUTRITION 74
626 SENSORY DISTURBANCE 74
627 SYSTEMIC LUPUS ERYTHEMATOSUS 74
628 THINKING ABNORMAL 74
629 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 73
630 CHOLECYSTITIS 73
631 LOCAL SWELLING 73
632 MUSCULOSKELETAL CHEST PAIN 73
633 AFFECTIVE DISORDER 72
634 HEPATIC FAILURE 72
635 MUSCULOSKELETAL DISCOMFORT 72
636 NEUROTOXICITY 72
637 PURPURA 72
638 RIB FRACTURE 72
639 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 72
640 DERMATITIS 71
641 DERMATITIS ATOPIC 71
642 GLOSSODYNIA 71
643 MULTIPLE SCLEROSIS RELAPSE 71
644 PRODUCT ADMINISTRATION INTERRUPTED 71
645 PULMONARY MASS 71
646 TOOTHACHE 71
647 URINE OUTPUT DECREASED 71
648 DIABETIC NEUROPATHY 70
649 DROOLING 70
650 ECZEMA 70
651 LIVER FUNCTION TEST ABNORMAL 70
652 MULTIPLE SCLEROSIS 70
653 VAGINAL HAEMORRHAGE 70
654 CARDIAC MURMUR 69
655 EJECTION FRACTION DECREASED 69
656 EXPIRED PRODUCT ADMINISTERED 69
657 GLOMERULAR FILTRATION RATE DECREASED 69
658 HERNIA 69
659 LACRIMATION INCREASED 69
660 PRODUCT PHYSICAL ISSUE 69
661 BLOOD PROLACTIN INCREASED 68
662 CLOSTRIDIUM DIFFICILE INFECTION 68
663 DENTAL CARIES 68
664 OVERWEIGHT 68
665 PRODUCT ADMINISTRATION ERROR 68
666 QUALITY OF LIFE DECREASED 68
667 SKIN INDURATION 68
668 DEVICE WIRELESS COMMUNICATION ISSUE 67
669 GASTROENTERITIS 67
670 GENERALISED OEDEMA 67
671 HAEMODIALYSIS 67
672 LUNG NEOPLASM MALIGNANT 67
673 MULTIPLE DRUG OVERDOSE 67
674 PREMATURE BABY 67
675 SPINAL PAIN 67
676 UPPER GASTROINTESTINAL HAEMORRHAGE 67
677 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 66
678 ANOREXIA 66
679 DIZZINESS POSTURAL 66
680 HIP ARTHROPLASTY 66
681 INFUSION SITE MASS 66
682 PROCTALGIA 66
683 PRURITUS GENERALISED 66
684 PULMONARY ARTERIAL HYPERTENSION 66
685 TRICUSPID VALVE INCOMPETENCE 66
686 AFFECT LABILITY 65
687 BEHAVIOUR DISORDER 65
688 DISABILITY 65
689 DRUG DOSE OMISSION BY DEVICE 65
690 INCONTINENCE 65
691 KNEE ARTHROPLASTY 65
692 MASS 65
693 SKIN HYPERTROPHY 65
694 BLOOD GLUCOSE ABNORMAL 64
695 DELUSION 64
696 DIVERTICULUM 64
697 EYE HAEMORRHAGE 64
698 HAIR COLOUR CHANGES 64
699 LUNG INFILTRATION 64
700 POST-TRAUMATIC STRESS DISORDER 64
701 PROCEDURAL PAIN 64
702 PRODUCT PREPARATION ERROR 64
703 SNEEZING 64
704 TACHYPNOEA 64
705 TOOTH DISORDER 64
706 CHOKING 63
707 CYANOSIS 63
708 DEVICE ALARM ISSUE 63
709 ELECTROCARDIOGRAM ABNORMAL 63
710 EXTRA DOSE ADMINISTERED 63
711 HAIR TEXTURE ABNORMAL 63
712 NODULE 63
713 RESPIRATORY TRACT INFECTION 63
714 BLOOD BILIRUBIN INCREASED 62
715 BLOOD MAGNESIUM DECREASED 62
716 DISSOCIATION 62
717 OBSESSIVE-COMPULSIVE DISORDER 62
718 SPINAL FRACTURE 62
719 CONJUNCTIVITIS 61
720 HYPERVOLAEMIA 61
721 ORAL CANDIDIASIS 61
722 PAIN OF SKIN 61
723 WOUND INFECTION 61
724 ATRIOVENTRICULAR BLOCK FIRST DEGREE 60
725 DEAFNESS 60
726 DRUG-INDUCED LIVER INJURY 60
727 FREQUENT BOWEL MOVEMENTS 60
728 INADEQUATE ANALGESIA 60
729 INHIBITORY DRUG INTERACTION 60
730 NEOVASCULARISATION 60
731 NEUTROPHIL COUNT DECREASED 60
732 OBSTRUCTIVE AIRWAYS DISORDER 60
733 PHOTOPHOBIA 60
734 RED BLOOD CELL SEDIMENTATION RATE INCREASED 60
735 SCREAMING 60
736 SPLENOMEGALY 60
737 TOOTH INFECTION 60
738 ACIDOSIS 59
739 BRAIN FOG 59
740 DRUG DISPENSING ERROR 59
741 ERECTILE DYSFUNCTION 59
742 FAECES DISCOLOURED 59
743 HYPOMAGNESAEMIA 59
744 INFECTION SUSCEPTIBILITY INCREASED 59
745 RASH PAPULAR 59
746 ROTATOR CUFF SYNDROME 59
747 SKIN TIGHTNESS 59
748 THERAPEUTIC RESPONSE SHORTENED 59
749 VENTRICULAR FIBRILLATION 59
750 APPLICATION SITE REACTION 58
751 HYPOVOLAEMIA 58
752 IMPAIRED DRIVING ABILITY 58
753 IMPLANT SITE PAIN 58
754 INFUSION SITE BRUISING 58
755 INFUSION SITE DISCOLOURATION 58
756 INITIAL INSOMNIA 58
757 LYMPHOEDEMA 58
758 TRISMUS 58
759 ULCER 58
760 ATAXIA 57
761 BACTERAEMIA 57
762 BODY HEIGHT DECREASED 57
763 BRUXISM 57
764 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 57
765 GLAUCOMA 57
766 INCORRECT ROUTE OF DRUG ADMINISTRATION 57
767 KLEBSIELLA INFECTION 57
768 PRODUCT STORAGE ERROR 57
769 RESPIRATORY TRACT CONGESTION 57
770 AUTOIMMUNE DISORDER 56
771 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 56
772 JUVENILE IDIOPATHIC ARTHRITIS 56
773 PARALYSIS 56
774 PSORIATIC ARTHROPATHY 56
775 WITHDRAWAL HYPERTENSION 56
776 AGEUSIA 55
777 APPLICATION SITE SWELLING 55
778 BODY TINEA 55
779 IMPULSIVE BEHAVIOUR 55
780 PERIPHERAL COLDNESS 55
781 PRESCRIBED UNDERDOSE 55
782 SPRUE-LIKE ENTEROPATHY 55
783 TYPE 1 DIABETES MELLITUS 55
784 ARTERIOSCLEROSIS CORONARY ARTERY 54
785 BLINDNESS UNILATERAL 54
786 CARPAL TUNNEL SYNDROME 54
787 CEREBRAL INFARCTION 54
788 COMPLICATION ASSOCIATED WITH DEVICE 54
789 EPIDURAL LIPOMATOSIS 54
790 EYE PRURITUS 54
791 FEMUR FRACTURE 54
792 GINGIVAL BLEEDING 54
793 GRAND MAL CONVULSION 54
794 HYPOCALCAEMIA 54
795 LIVER FUNCTION TEST INCREASED 54
796 MUSCLE RIGIDITY 54
797 NEEDLE ISSUE 54
798 PRODUCT DISPENSING ERROR 54
799 PSYCHOLOGICAL TRAUMA 54
800 RENAL TRANSPLANT 54
801 SMALL INTESTINAL OBSTRUCTION 54
802 VASCULITIS 54
803 VENTRICULAR EXTRASYSTOLES 54
804 ABDOMINAL PAIN LOWER 53
805 BLOOD IRON DECREASED 53
806 BRONCHOSPASM 53
807 BUNDLE BRANCH BLOCK LEFT 53
808 FIBROSIS 53
809 HEPATIC CIRRHOSIS 53
810 HYPERTENSIVE EMERGENCY 53
811 HYPERVENTILATION 53
812 HYPOVENTILATION 53
813 POLYURIA 53
814 PRODUCT DOSE OMISSION IN ERROR 53
815 RESPIRATORY RATE INCREASED 53
816 SALIVARY HYPERSECRETION 53
817 SUBSTANCE ABUSE 53
818 TRANSFUSION 53
819 BLOOD COUNT ABNORMAL 52
820 EPILEPSY 52
821 INTERVERTEBRAL DISC DISORDER 52
822 JAUNDICE 52
823 NEUROLOGICAL SYMPTOM 52
824 PHOTOSENSITIVITY REACTION 52
825 PLASMA CELL MYELOMA 52
826 TOOTH FRACTURE 52
827 VITAMIN D DEFICIENCY 52
828 ABDOMINAL TENDERNESS 51
829 ACUTE CORONARY SYNDROME 51
830 APPLICATION SITE DISCOLOURATION 51
831 BACK INJURY 51
832 BRAIN OEDEMA 51
833 DEVICE PHYSICAL PROPERTY ISSUE 51
834 DISTRIBUTIVE SHOCK 51
835 FLANK PAIN 51
836 GASTRIC ULCER 51
837 LYMPHOCYTE COUNT DECREASED 51
838 MADAROSIS 51
839 MEDICAL DEVICE COMPLICATION 51
840 THYROID DISORDER 51
841 TOOTH ABSCESS 51
842 ACCIDENT 50
843 ANAL INCONTINENCE 50
844 ANAPHYLACTIC SHOCK 50
845 BLOOD CALCIUM DECREASED 50
846 HYPERTHERMIA 50
847 IRON DEFICIENCY ANAEMIA 50
848 MULTIPLE INJURIES 50
849 NERVE INJURY 50
850 OPPOSITIONAL DEFIANT DISORDER 50
851 RALES 50
852 SCOLIOSIS 50
853 ATRIOVENTRICULAR BLOCK 49
854 BODY TEMPERATURE DECREASED 49
855 DEVICE CONNECTION ISSUE 49
856 HAEMOGLOBIN INCREASED 49
857 HELICOBACTER INFECTION 49
858 HYPERREFLEXIA 49
859 HYPOAESTHESIA ORAL 49
860 IMPLANT SITE EXTRAVASATION 49
861 ISCHAEMIC STROKE 49
862 LOWER GASTROINTESTINAL HAEMORRHAGE 49
863 NOCTURIA 49
864 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 49
865 PNEUMONITIS 49
866 SUBARACHNOID HAEMORRHAGE 49
867 VICTIM OF CHILD ABUSE 49
868 DRUG LEVEL DECREASED 48
869 ECCHYMOSIS 48
870 HAIR DISORDER 48
871 HUNGER 48
872 INFUSION SITE INFLAMMATION 48
873 MULTIPLE FRACTURES 48
874 MUSCULOSKELETAL DISORDER 48
875 ORAL DISCOMFORT 48
876 PULSELESS ELECTRICAL ACTIVITY 48
877 SKIN ATROPHY 48
878 TASTE DISORDER 48
879 ATRIAL FLUTTER 47
880 BLOOD PRESSURE DIASTOLIC DECREASED 47
881 DECUBITUS ULCER 47
882 DRUG ADMINISTERED AT INAPPROPRIATE SITE 47
883 ERUCTATION 47
884 HYPERCALCAEMIA 47
885 OESOPHAGITIS 47
886 SKIN CANCER 47
887 SKIN LACERATION 47
888 TRANSPLANT REJECTION 47
889 UNINTENTIONAL MEDICAL DEVICE REMOVAL 47
890 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 46
891 BLOOD GLUCOSE FLUCTUATION 46
892 FEELING OF BODY TEMPERATURE CHANGE 46
893 LACERATION 46
894 MAJOR DEPRESSION 46
895 MUSCLE ATROPHY 46
896 PERIPHERAL VASCULAR DISORDER 46
897 PLATELET COUNT INCREASED 46
898 PNEUMOTHORAX 46
899 SPINAL DISORDER 46
900 STRESS CARDIOMYOPATHY 46
901 TEMPERATURE INTOLERANCE 46
902 TORSADE DE POINTES 46
903 ALCOHOLISM 45
904 BLOOD ALBUMIN DECREASED 45
905 DEFORMITY 45
906 DEVICE ADHESION ISSUE 45
907 DRUG ABUSER 45
908 HEAD DISCOMFORT 45
909 HEPATOMEGALY 45
910 INCREASED TENDENCY TO BRUISE 45
911 INFUSION SITE DISCOMFORT 45
912 INFUSION SITE RASH 45
913 INSURANCE ISSUE 45
914 PARKINSON^S DISEASE 45
915 REBOUND EFFECT 45
916 REFUSAL OF TREATMENT BY PATIENT 45
917 SCAB 45
918 AUTISM SPECTRUM DISORDER 44
919 AUTONOMIC NERVOUS SYSTEM IMBALANCE 44
920 DRUG RESISTANCE 44
921 HAEMODYNAMIC INSTABILITY 44
922 MONOPLEGIA 44
923 OESOPHAGEAL PAIN 44
924 PRODUCT USE COMPLAINT 44
925 SKIN FISSURES 44
926 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 44
927 STREPTOCOCCAL INFECTION 44
928 SUBDURAL HAEMATOMA 44
929 BEDRIDDEN 43
930 CLOSTRIDIUM DIFFICILE COLITIS 43
931 COLITIS ULCERATIVE 43
932 DEVICE KINK 43
933 DIABETIC RETINOPATHY 43
934 DRUG WITHDRAWAL SYNDROME NEONATAL 43
935 HYDRONEPHROSIS 43
936 INGUINAL HERNIA 43
937 PETECHIAE 43
938 SOMNAMBULISM 43
939 VITAMIN D DECREASED 43
940 WRIST FRACTURE 43
941 ANGINA UNSTABLE 42
942 CHILD ABUSE 42
943 HAEMORRHAGIC ANAEMIA 42
944 HAEMORRHAGIC STROKE 42
945 HEPATITIS 42
946 HEPATOTOXICITY 42
947 HYPOALBUMINAEMIA 42
948 INCOHERENT 42
949 INTERSTITIAL LUNG DISEASE 42
950 MALIGNANT HYPERTENSION 42
951 SEDATION COMPLICATION 42
952 SENSORY LOSS 42
953 SINUS CONGESTION 42
954 COLITIS ISCHAEMIC 41
955 EXOSTOSIS 41
956 EXTRASYSTOLES 41
957 FACIAL PAIN 41
958 IMPLANT SITE INFECTION 41
959 INJECTION SITE INDURATION 41
960 INTERNAL HAEMORRHAGE 41
961 LIGAMENT SPRAIN 41
962 PARAESTHESIA ORAL 41
963 PAROSMIA 41
964 PELVIC PAIN 41
965 ABSCESS 40
966 AMENORRHOEA 40
967 AORTIC ANEURYSM 40
968 APPLICATION SITE URTICARIA 40
969 CHOLESTASIS 40
970 ESCHERICHIA URINARY TRACT INFECTION 40
971 FAILURE TO THRIVE 40
972 GASTROINTESTINAL PAIN 40
973 HYPERTENSIVE HEART DISEASE 40
974 INCORRECT DOSE ADMINISTERED BY DEVICE 40
975 PROTEIN URINE PRESENT 40
976 VASCULAR DEVICE INFECTION 40
977 WRONG DRUG ADMINISTERED 40
978 BASAL CELL CARCINOMA 39
979 BLOOD LACTATE DEHYDROGENASE INCREASED 39
980 CHOLECYSTECTOMY 39
981 CHOREOATHETOSIS 39
982 DEVICE INFORMATION OUTPUT ISSUE 39
983 DRUG USE DISORDER 39
984 ENTEROCOCCAL INFECTION 39
985 EUPHORIC MOOD 39
986 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 39
987 NEOPLASM PROGRESSION 39
988 PSYCHIATRIC SYMPTOM 39
989 SCRATCH 39
990 SKIN HAEMORRHAGE 39
991 SPINAL COLUMN STENOSIS 39
992 THERAPY CHANGE 39
993 BLOOD PRESSURE DIASTOLIC INCREASED 38
994 CARDIAC VALVE DISEASE 38
995 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 38
996 ENURESIS 38
997 FAECAL INCONTINENCE 38
998 FAECALOMA 38
999 GROIN PAIN 38